Skip to content
Clinical Trials – home

Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila

Verified siteinfo

Romania Strada Vulcanescu Mircea 88, 010825 Bucharest, Romania

  • 18 trials recruiting
  • Colitis ulcerative · Dementia Alzheimer's type · Bipolar I disorder
  • Adults and children

About Specializations

Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila in Bucharest, Romania specialises in clinical trials of conditions such as Colitis ulcerative, Dementia Alzheimer's type, Bipolar I disorder, Crohn's disease, and other specialisations. This site conducts important research.

Main research areas of the site

Stomatognathic Diseases and Oral Surgery

Clinical research at Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila includes studies in stomatognathic diseases focused on preventing bleeding complications after tooth extraction in patients using blood-thinning medicines. The work is aimed at improving oral bleeding control and supporting safer dental care for people at higher risk of postoperative bleeding.

  • Preventing clinically relevant bleeding after single or multiple tooth extraction
  • Evaluating a new oral approach to reduce postoperative oral bleeding and hematomas
  • Supporting safer procedures for patients treated with anticoagulants

This area reflects a practical effort to improve treatment safety and patient outcomes in dentistry and oral medicine.

Bacterial Infections and Urology

The site is also conducting research in bacterial infections related to complicated urinary tract infection and acute pyelonephritis. These studies are designed to compare treatment effectiveness in hospitalized adults and to help identify better options for managing serious urinary infections.

  • Complicated urinary tract infection
  • Acute pyelonephritis
  • Testing an oral antibiotic option against standard intravenous therapy

This research supports advances in urology by exploring whether new treatment strategies can deliver effective infection control while improving convenience for patients and clinicians.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Vulcanescu Mircea 88010825 BucharestRomania
Recruiting now
18 trials
Conditions studied
30
Partner status
Verified site

More sites in BucharestRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

37 clinical trials

Orforglipron for stress urinary incontinence in women with obesity or overweight

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Sponsor:Eli Lilly & Co.

Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Seaport Therapeutics Inc.

Bipolar I disorder+1

Recruiting

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Seaport Therapeutics Inc.

Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.